Skip to content
Tenfell
Awarded contract
Published 13 Dec 2024

NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin

NHS England · London

Key facts

Contract value
£1,600,000,000
Awarded
22 Jun 2021
Contract starts
30 Jun 2021
Contract ends
31 Mar 2025
Buyer type
Central government

Awarded to

SupplierValue
Bio Products Laboratory£1,600,000,000

Description

This modification notice is to provide notice of the modification of the framework agreement (as defined below) to (i) extend its duration with a limited number of suppliers and (ii) increase the estimated value of the framework agreement across all lots. The modification is further described in sections VII.2.1 and VII.2.2 below, but in short NHS England were required to (i) modify the Current Framework with the Absent Suppliers (as defined below) so as to extend the Current Framework for those Absent Products (as defined below) for a further period of (i) 3-months for IVIg products (Lots 1, 2, 5 and 6) (so to 30th September 2025) and (ii) 6-months for SCIg products (Lots 3 and 7) (so to 31st December 2025) and (ii) increase the estimated value of the Current Framework from £1.2bn to £1.6bn (an increase of 33%).

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.